中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2013

Please select

AUG
20

The United Laboratories International Holdings Limited Announces 2013 Interim Results, Turnover Increased to HK$3.75 Billion, Achieved Stable Business Growth, The Recombinant Human Insulin Products to Capture a Larger Market Share

MAR
28

The United Laboratories International Holdings Limited Announces 2012 Annual Results, Turnover Increased to HK$7.02 Billion, Gross Profit and Profit Attributable to Equity Holders Increased Significantly, Overall Business Performance Improved, Sales and R&D Progress of Human Insulin Products Better than Expected